AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12059892
Drug: Mivacurium (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium (0.1 mg/kg bolus followed by continuous infusion)
Trial: 9522671
Drug: Aspirin 2
RxNorm normalized name: aspirin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 2 x 500 mg (acetylsalicylic acid)
Trial: 7510063
Drug: Nurse home
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse home visitation during pregnancy (treatment 3)
Trial: 7510063
Drug: Nurse home
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse home visitation during pregnancy and the first 2 years of the child's life (treatment 4)
Trial: 7510063
Drug: Sensory and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensory and developmental screening at ages 1 and 2 years (treatment 1)
Trial: 7510063
Drug: Screening plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Screening plus free transportation for prenatal and well‐child care (treatment 2)
Trial: 796937
Drug: Ketoprofen 100
RxNorm normalized name: ketoprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 100 mg/day
Trial: 26510086
Drug: Fluvastatin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin + Standard of Care (SOC) therapy (PEG-IFN/Ribavirin) for 48 weeks
Trial: 26510086
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of Care (SOC) therapy (PEG-IFN/Ribavirin) for 48 weeks
Trial: 21606531
Drug: H5N1 A/Indonesia/05/2005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H5N1 A/Indonesia/05/2005 vaccine (3.75 μg hemagglutinin antigen, AS03(A) adjuvanted)
Trial: 8136093
Drug: Verapamil SR
RxNorm normalized name: Dom-Verapamil SR
DrugBank: Verapamil (DB00661)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Verapamil SR (240 to 480 mg/day)
Trial: 30030128
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) ghrelin
Trial: 18028434
Drug: G‐CSF +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF + EPO
Trial: 12918185
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg morphine sulfate p.o. approximately one hour before surgery
Trial: 11583481
Drug: Rofecoxib 12.5
RxNorm normalized name: rofecoxib 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 12.5 mg once daily
Trial: 23993259
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg 3 times daily
Trial: 8211024
Drug: Pravastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (20 to 40 mg daily)
Trial: 20889387
Drug: Lidocaine patch
RxNorm normalized name: LIDOCAINE 40 mg TOPICAL PATCH [Lidocaine Patch]
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine patch
Trial: 29395412
Drug: Depressomassage (additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depressomassage (additional to standard physical therapy)
Trial: 24812900
Drug: Lingtong Capsule
RxNorm normalized name: BUTYLENE GLYCOL 1.6 g in 8 g CUTANEOUS TAPE [LingLongJiuHuo Linglong Moxibustion]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lingtong Capsule (LC)
Trial: 23192920
Drug: 1 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 × 10(5) autologous CD34+ cells/kg (low-dose)
Trial: 23192920
Drug: 1 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 × 10(6) autologous CD34+ cells/kg (high-dose)
Trial: 15607843
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose buprenorphine (HD, 8‐8‐8‐4‐2 mg/day on days 1‐5)
Trial: 15607843
Drug: Clonidine (C,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (C, 0.2‐0.3‐0.3‐0.2‐0.1 mg QID on days 1‐5)
Trial: 15607843
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose buprenorphine (HD)
Trial: 7548807
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy for 1 week (Group IIa, n = 16)
Trial: 7548807
Drug: No drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drugs (Group I, n = 29)
Trial: 7548807
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (2 weeks) for patients whose ulcer recurred after nizatidine
Trial: 2170104
Drug: Instant bean
RxNorm normalized name: Bean
DrugBank: Bean (DB14709)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instant bean flakes (174 g/d)
Trial: 2170104
Drug: Potato flakes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potato flakes (102 g/d)
Trial: 6993442
Drug: Continuous radiation
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous radiation therapy (30 fractions of 220 rad each, total dose of 6600 rad)
Trial: 20858487
Drug: BIBW 2948
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIBW 2948 BS (EGFR kinase domain inhibitor), inhalatively administered
Trial: 20550864
Drug: Intrathecal isobaric
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal isobaric ropivacaine (15 mg)
Trial: 11435650
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside (SNP) infusion in CPB
Trial: 11435650
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of isoflurane inhalation (0.2-0.5%) + SNP in low doses (<1mg/kg/min)
Trial: 8384887
Drug: ACTH1-24 (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACTH1-24 (various doses)
Trial: 31167889
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus Rosiglitazone (M + R)
Trial: 20356587
Drug: Metformin (M)
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (M)
Trial: 31167889
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus Lifestyle (M + L)
Trial: 23518003
Drug: In-surgery bleaching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-surgery bleaching with light activated 25% hydrogen peroxide gel followed by 2 weeks at home, night time bleaching with 10% carbamide peroxide gel in a customised bleaching tray.
Trial: 23518003
Drug: In-surgery bleaching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-surgery bleaching with 25% hydrogen peroxide without light activation followed by 2 weeks at home, night time bleaching with 10% carbamide peroxide gel in a customised bleaching tray.
Trial: 9237092
Drug: Guided Imagery
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided Imagery and Music (GIM) therapy
Trial: 7954026
Drug: Sustained-release isosorbide
RxNorm normalized name: isosorbide Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release isosorbide dinitrate (ISDN) 40 mg twice daily
Trial: 29278279
Drug: Camicinal 50
RxNorm normalized name: Camicinal
DrugBank: Camicinal (DB12567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Camicinal 50 mg once-daily
Trial: 27421242
Drug: Azilsartan (AZL)
DrugBank: Azilsartan medoxomil (DB08822)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azilsartan (AZL) 5 mg
Trial: 27421242
Drug: Azilsartan (AZL)
DrugBank: Azilsartan medoxomil (DB08822)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azilsartan (AZL) 10 mg
Trial: 27421242
Drug: Azilsartan (AZL)
DrugBank: Azilsartan medoxomil (DB08822)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azilsartan (AZL) 20 mg
Trial: 27421242
Drug: Azilsartan (AZL)
DrugBank: Azilsartan medoxomil (DB08822)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azilsartan (AZL) 40 mg
Trial: 11440284
Drug: Telmisartan 40
RxNorm normalized name: telmisartan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 40 mg/HCTZ 12.5 mg
Trial: 11440284
Drug: Telmisartan 80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 80 mg/HCTZ 12.5 mg
Trial: 10569261
Drug: Abduction orthosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abduction orthosis treatment initiated at approximately 4 months of age in 6 cases with persisting dysplasia
Trial: 10569261
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (87 children)
Trial: 10569261
Drug: Abduction orthosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abduction orthosis treatment
Trial: 29383480
Drug: BoNT-A prostatic
RxNorm normalized name: BoNT/A-DS
DrugBank: LetibotulinumtoxinA (DB16820)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BoNT-A prostatic injection (200 UI)
Trial: 27221799
Drug: Optimized medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimized medical therapy
Trial: 29083439
Drug: n-3 PUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA supplementation (DHA 800 mg and EPA 225 mg daily for 3 years)
Trial: 29083439
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical capsules comprising liquid paraffin oil)
Trial: 26266835
Drug: Transparent perfluorodecalin
RxNorm normalized name: Perfluorodecalin
DrugBank: Perfluorodecalin (DB16292)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transparent perfluorodecalin (PFD) infused patch with Q-switched Alexandrite laser (755 nm)
Trial: 6755255
Drug: Less intense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less intense anticoagulant therapy (mean prothrombin time of 26.9 seconds, Simplastin time 15 seconds)
Trial: 6755255
Drug: More intense
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More intense anticoagulant therapy (mean Simplastin time of 19.4 seconds, prothrombin time 41 seconds)
Trial: 30513231
Drug: Stimulant and
RxNorm normalized name: norgestimate and ethinylestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant and non-stimulant treatments for ADHD
Trial: 25350959
Drug: etravirine 200
RxNorm normalized name: etravirine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etravirine 200 mg bid
Trial: 15213060
Drug: Hypertonic NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic NaCl solution infusion (855 mmol/l) followed by free access to water
Trial: 7653793
Drug: Propofol/alfentanil anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol/alfentanil anaesthesia (propofol 2 mg/kg, alfentanil 15 micrograms/kg, maintained by infusion of propofol and alfentanil)
Trial: 25922978
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml bupivacaine
Trial: 25922978
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml bupivacaine with 100 μg of fentanyl
Trial: 25922978
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml bupivacaine with 100 ng naloxone
Trial: 22030144
Drug: Foley catheter
RxNorm normalized name: Bard Foley Catheter 18FR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foley catheter (30 mL)
Trial: 8610776
Drug: Vaginal prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal prostaglandin E2 gel
Trial: 12722173
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy for 3 weeks during a 20-week spa period
Trial: 9189963
Drug: Placebo (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5 ml of water)
Trial: 1552106
Drug: rt-PA (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rt-PA (100 mg with an initial bolus dose of 15 mg followed by an infusion of 50 mg over 30 min and 35 mg over 60 min)
Trial: 3910726
Drug: H142 (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H142 (1.0 and 2.5 mg/kg per h)
Trial: 17939171
Drug: Diltiazem (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (120 mg single dose)
Trial: 16099718
Drug: 4.5 g
RxNorm normalized name: Zosyn 4.5 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 g sodium oxybate nightly for 8 weeks
Trial: 8578179
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice daily for 6 weeks
Trial: 383276
Drug: Cyclophosphamide 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide 600 mg/m2 IV on day 1 plus DTIC 200 mg/m2 IV days 1 through 5
Trial: 383276
Drug: Cyclophosphamide 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide 600 mg/m2 IV on day 1 plus DTIC 200 mg/m2 IV days 1 through 5 plus C. parvum 5 mg/m2 IV on day 8 and day 15
Trial: 3653591
Drug: Diltiazem 240
RxNorm normalized name: diltiazem 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 240 mg/day
Trial: 24695896
Drug: Vitamin D₃
RxNorm normalized name: vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D₃ (20 μg/d)
Trial: 20389255
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate 100 mg eq.
Trial: 19941696
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate (both doses)
Trial: 12139269
Drug: Paracetamol 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 1000 mg plus codeine 30 mg
Trial: 7041936
Drug: Paracetamol 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 1000 mg alone
Trial: 9865013
Drug: Therapeutic plasmapheresis
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic plasmapheresis (TP) + alpha-tocopherol treatment (AT)
Trial: 8560531
Drug: Artemether (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemether (4 mg/kg/d for 3 d) + mefloquine (25 mg/kg)
Trial: 8560531
Drug: Mefloquine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine alone (25 mg/kg)
Trial: 350262
Drug: Propranolol, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, 40 mg three times daily
Trial: 28722100
Drug: Integrative-psychotherapeutic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrative-psychotherapeutic treatment program consisting of 16 weekly sessions including vestibular rehabilitation training and modules for anxiety, panic disorder, depression, and somatisation.
Trial: 26638592
Drug: Direct field
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct field block with 40 ml of 0.125% bupivacaine
Trial: 26638592
Drug: Spinal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal block with intrathecal morphine (Control)
Trial: 17047615
Drug: 10 mg/day
RxNorm normalized name: Adlarity 10 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/day atorvastatin
Trial: 11005043
Drug: ECT with
RxNorm normalized name: Nexa Select with DHA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ECT with high dosage (2.5 times seizure threshold)
Trial: 28535410
Drug: Perampanel 1mg
RxNorm normalized name: Perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Perampanel 1mg with ketoconazole 400mg once daily for 10 days
Trial: 28535410
Drug: Ketoconazole 400mg
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole 400mg once daily for 10 days
Trial: 28535410
Drug: Simulations with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simulations with a more potent inhibitor than ketoconazole (e.g., itraconazole)
Trial: 24155139
Drug: Tocilizumab (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab (intravenous dose based on body weight every 2 or 4 weeks)
Trial: 16818571
Drug: Folate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Folate (5 mg daily)
Trial: 16818571
Drug: Vitamin B6
RxNorm normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B6 (100 mg daily)
Trial: 1319619
Drug: Logiparin (2,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Logiparin (2,500 anti-Xa units once daily)
Trial: 1319619
Drug: Logiparin (3,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Logiparin (3,500 anti-Xa units once daily)
Trial: 1319619
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (5,000 IU twice daily)
Trial: 24423921
Drug: Axitinib 10
RxNorm normalized name: Axitinib
DrugBank: Axitinib (DB06626)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Axitinib 10 mg b.i.d. combined with FOLFIRI or FOLFOX
Trial: 18031439
Drug: Nonsubmerged surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsubmerged surgical technique (198 implants)
Trial: 18031439
Drug: Submerged surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Submerged surgical technique (206 implants)
Trial: 16563590
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg citalopram
Trial: 12588933
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg reboxetine
Trial: 29471300
Drug: Zevalin (Yttrium-90-Ibritumomab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zevalin (Yttrium-90-Ibritumomab Tiuxetan) after 2 cycles of ESHAP chemotherapy
Trial: 19699454
Drug: 5mg of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5mg of oxybutynin in sublingual form (Group O)
Trial: 1397884
Drug: Norfloxacin, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin, 400 mg orally or through a nasogastric tube, twice daily for 7 days
Trial: 3892729
Drug: Ketoconazole 400
RxNorm normalized name: ketoconazole 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 400 mg/d
Trial: 29627596
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (1200 mg/day of eicosapentaenoic acid and 600 mg/day of docosahexaenoic acid)
Trial: 23513399
Drug: Placebo pills
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo pills
Trial: 8465360
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg daily
Trial: 12060436
Drug: Oxybutynin 5
RxNorm normalized name: oxyBUTYnin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin 5 mg bid
Trial: 10417452
Drug: Morphine 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.75 mg plus alfentanil 0.125 mg (Group MA)
Trial: 10417452
Drug: Morphine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 1.5 mg alone (Group M)
Trial: 2107519
Drug: Concurrent administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent administration of Haemophilus influenzae type b conjugate vaccine with diphtheria-tetanus-pertussis and oral poliovirus vaccines
Trial: 424753
Drug: Fentanyl (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (intravenous administration)
Trial: 26522499
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy plus Pulmonary Rehabilitation (PR)
Trial: 21370402
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy followed by tumor resection
Trial: 21370402
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and tumor resection
Trial: 19135570
Drug: Doxycycline 200
RxNorm normalized name: doxycycline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 200 mg given 4 hours before D&E (Group 1)
Trial: 3071603
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (Group A)
Trial: 14750898
Drug: Standard-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose chemotherapy
Trial: 19824078
Drug: Betaine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaine (20 g daily)
Trial: 16978993
Drug: Facilitated angioplasty
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Facilitated angioplasty with full- or half-dose thrombolysis
Trial: 11704586
Drug: Inhaled IL-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled IL-5 (15 microg)
Trial: 11704586
Drug: Intravenous IL-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous IL-5 (2 microg)